Represented SPK Acquisition Corp. in its business combination with Varian Biopharmaceuticals, Inc.

Represented SPK Acquisition Corp. in its initial business combination with Varian Biopharmaceuticals, Inc., a private precision oncology company developing novel therapeutics for the treatment of cancer.